For extra-pancreatic functions of GLP-1 and its based diabetes drugs, please see nice review and other publications elsewhere
Symptoms that continue, worsen, return after each meal, interrupt sleep, or prevent normal hydration deserve clinical review
The New England Journal of Medicine , 384, 9891002
If you're struggling like I was, dont give up
The GLP-1 Bridge program will cover three drugs, Foundayo, Wegovy and Zepbound, and be available to people who have Medicare Part D, an optional extra coverage to lower the cost of prescriptions
The result: Reduced appetite You feel genuinely satisfied with less food, not deprived Fewer cravings The constant mental chatter about food quiets down Slower digestion Food stays in your stomach longer, keeping you full between meals Better blood sugar control Fewer energy crashes and hunger spikes throughout the day Cardiovascular benefits Research shows reduced risk of heart attacks and strokes in people taking GLP-1 medications This isnt willpower in a syringe